Fluorescent Intra-operative Tumor Margin Examination

PHASE2RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sarcoma
Interventions
DRUG

Indocyanine green solution administered at 2.0mg/kg.

Dosing of ICG to be administered at 2.0mg/kg, two hours prior to surgery.

DEVICE

Stryker SPY-PHI Imaging Device

The SPY-PHI system is used with the ICG dye to provide fluorescence images.

Trial Locations (1)

15213

RECRUITING

UPMC-Shadyside Hospital, Pittsburgh

All Listed Sponsors
collaborator

Stryker Nordic

INDUSTRY

lead

Kurt Weiss

OTHER